650 related articles for article (PubMed ID: 21397569)
1. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
[TBL] [Abstract][Full Text] [Related]
2. Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169.
Granero D; Pérez-Calatayud J; Ballester F; Bos AJ; Venselaar J
Radiat Prot Dosimetry; 2006; 118(1):11-5. PubMed ID: 16030058
[TBL] [Abstract][Full Text] [Related]
3. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
4. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
[TBL] [Abstract][Full Text] [Related]
5. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
Morton GC; Sankreacha R; Halina P; Loblaw A
Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma.
Wang Y; Sankreacha R; Al-Hebshi A; Loblaw A; Morton G
Brachytherapy; 2006; 5(4):251-5. PubMed ID: 17118319
[TBL] [Abstract][Full Text] [Related]
7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
8. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
9. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy.
Hsu IC; Lessard E; Weinberg V; Pouliot J
Brachytherapy; 2004; 3(3):147-52. PubMed ID: 15533807
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
[TBL] [Abstract][Full Text] [Related]
12. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
[TBL] [Abstract][Full Text] [Related]
13. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
[TBL] [Abstract][Full Text] [Related]
17. Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?
Famulari G; Alfieri J; Duclos M; Vuong T; Enger SA
Brachytherapy; 2020; 19(2):255-263. PubMed ID: 31964601
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
Zilio VO; Joneja OP; Popowski Y; Chawla R
Brachytherapy; 2004; 3(4):201-14. PubMed ID: 15607152
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific Monte Carlo-based dose-kernel approach for inverse planning in afterloading brachytherapy.
D'Amours M; Pouliot J; Dagnault A; Verhaegen F; Beaulieu L
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1582-9. PubMed ID: 21075547
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo calculation of the dose perturbations in a dual-source HDR/PDR afterloader treatment unit.
Collins-Fekete CA; Plamondon M; Verhaegen F; Beaulieu L
Brachytherapy; 2016; 15(4):524-530. PubMed ID: 27317950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
